Drug Profile
Research programme: cardiovascular therapeutics - LG Chem/Institut Pasteur Korea
Latest Information Update: 17 Aug 2017
Price :
$50
*
At a glance
- Originator Institut Pasteur Korea; LG Life Sciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cardiovascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cardiovascular-disorders in South Korea
- 19 Jun 2007 New profile
- 19 Jun 2007 Preclinical trials in Cardiovascular disorders in South Korea (unspecified route)